A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice
Completed
354 enrolled
TraveraRTGx
Completed
72 enrolled
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Completed
140 enrolled
DP-04
Recruiting
100 enrolled
OVAmiARN
Active not recruiting
746 enrolled
OLIVIA
Recruiting
250 enrolled
SCOUT-1
Recruiting
750 enrolled
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Recruiting
25 enrolled
BASECAMP-1
Recruiting
200 enrolled
FORCE
Not yet recruiting
200 enrolled
SMARAGD
Recruiting
1,975 enrolled
EXoPERT EMERALD Clinical Study
Recruiting
1,400 enrolled
CAMPERR
Recruiting
7,000 enrolled
SCORE
Recruiting
9,600 enrolled
CCANED-CIPHER
Recruiting
6,000 enrolled
HERGYN
Completed
509 enrolled
Clinical Pre-screening Protocol for Ovarian Cancer
Recruiting
60 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients
Completed
1,018 enrolled
OVAL-1
Completed
342 enrolled
OLAP
Completed
661 enrolled
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Terminated
19 enrolled
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs
Completed
7 enrolled
DESCENT-1
Enrolling by invitation
400 enrolled
OVARD
Active not recruiting
400 enrolled
START
Terminated
10 enrolled
BARHYSTER
Recruiting
132 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
PREFER
Completed
1,429 enrolled
ChemoINtel
Recruiting
100 enrolled
INSPIRE
Recruiting
5,350 enrolled
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass
Recruiting
1,000 enrolled
GynRNA
Recruiting
2,500 enrolled
ROOT
Completed
167 enrolled
A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea
Completed
662 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
QUANTUM
Enrolling by invitation
3,000 enrolled
RADIANT
Completed
16 enrolled
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA and Immune Repertoire
Active not recruiting
104 enrolled
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
Not yet recruiting
80 enrolled
VOCAL
Completed
1,025 enrolled
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
C-PATROL
Completed
276 enrolled
Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
Not yet recruiting
500 enrolled
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Unknown
500 enrolled
EMBER
Completed
200 enrolled
Appraising Medical Trial Experiences of Ovarian Cancer Patients
Not yet recruiting
500 enrolled
3D-PREDICT
Unknown
570 enrolled
CADENCE
Unknown
15,000 enrolled
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Unknown
3,000 enrolled